<div id="readability-page-1"><div><div><p>U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.</p><p>Shares of <strong>Intel Corporation</strong> <span>INTC</span> fell in pre-market trading following second-quarter results.</p><p>Intel reported a loss for the second quarter, while sales topped estimates. Intel expects third-quarter revenue to be in the range of $12.6 billion to $13.6 billion, versus estimates of $12.63 billion. The company anticipates a third-quarter loss of 24 cents per share versus estimates for a loss of 18 cents per share. Intel CEO Lip-Bu Tan shared a memo with employees saying that the company will reduce its workforce to 75,000 employees by the end of the year through layoffs and attrition.</p><p>Intel shares dipped 5.9% to $21.30 in the pre-market trading session.</p><div><div><div><p>Trending Investment Opportunities</p></div></div></div><p>Here are some other stocks moving lower in pre-market trading.</p><ul> <li><strong>Absci Corporation</strong> <span>ABSI</span> declined 13.7% to $3.03 in pre-market trading after the company announced the pricing of public offering of common stock.</li> <li><strong>AST SpaceMobile, Inc</strong>. <span>ASTS</span> fell 9.2% to $54.56 in pre-market trading after the company announced a $500 million private offering of convertible senior notes.</li> <li><strong>Almonty Industries Inc</strong>. <span>ALM</span> dipped 8.5% to $4.06 in pre-market trading.</li> <li><strong>Synovus Financial Corp</strong>. <span>SNV</span> fell 8.3% to $51.88 in pre-market trading. Pinnacle and Synovus announced an $8.6 billion all-stock merger.</li> <li><strong>Sarepta Therapeutics, In</strong>c. <span>SRPT</span> declined 5.2% to $12.20 in pre-market trading. Citigroup analyst Yigal Nochomovitz, on Thursday, initiated coverage on Sarepta Therapeutics with a Sell rating and announced a price target of $7.</li> <li><strong>ABIVAX Société Anonym</strong>e <span>ABVX</span> fell 4% to $66.99 in pre-market trading. Abivax announced full exercise of underwriters’ option to purchase additional ADSs, bringing gross proceeds of offering to $747.5 million (€637.5 million).</li> <li><strong>Semler Scientific, Inc</strong>. <span>SMLR</span> fell 3.6% to $37.50 in pre-market trading.</li> </ul><p><strong>Now Read This: </strong></p><ul> <li><strong>Top 2 Tech Stocks You May Want To Dump This Quarter</strong></li> </ul><p>Photo via Shutterstock</p></div></div></div>

ASTS

INTC

<p>U.S. stock futures were mixed, with Dow futures up 0.1%. Intel shares fell 5.9% in pre-market trading after reporting a second-quarter loss and announcing workforce reductions. Absci Corporation dropped 13.7% following a public offering announcement, while AST SpaceMobile fell 9.2% after a $500 million private offering. Other notable declines included Almonty Industries (-8.5%), Synovus Financial (-8.3%), and Sarepta Therapeutics (-5.2%) after a Sell rating from Citigroup. Overall, several stocks are moving lower in pre-market trading.</p>

- U.S. stock futures showed mixed results, with Dow futures up 0.1% on Friday.  
- Intel Corporation reported a second-quarter loss despite exceeding sales estimates and anticipates a third-quarter revenue of $12.6 billion to $13.6 billion, alongside a projected loss of 24 cents per share.  
- Several other stocks, including Absci Corporation and AST SpaceMobile, experienced significant declines in pre-market trading following various announcements.  

Benzinga

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session